Payden & Rygel’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Payden & Rygel's CL Position: Q1 2021 in Review
Payden & Rygel sold out of Colgate-Palmolive (CL) in Q1 2021, closing a stake of 600 shares — an estimated $51K sold.
Payden & Rygel first reported a position in CL in Q2 2013 and held it in 31 quarters. The position peaked at $55K in Q4 2015. 1,608 funds tracked by Wall St. Rank hold CL as of Q1 2021.
- Payden & Rygel reported no remaining Colgate-Palmolive position as of Q1 2021 after selling out during the quarter.
- Payden & Rygel sold 600 Colgate-Palmolive shares in Q1 2021, an estimated $51K.
- Payden & Rygel first reported a position in Colgate-Palmolive in Q2 2013 and held it in 31 quarters.
- Payden & Rygel's Colgate-Palmolive position peaked at $55K in Q4 2015.
- 1,608 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2021.
Based on Payden & Rygel's 13F filing for Q1 2021, filed 13 May 2021.